Literature DB >> 28606406

[Quality of life in patients with autosomal dominant polycystic kidney disease].

Laurent Lecardeur1, Dominique Joly2.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disease that usually occurs in adulthood. The majority of affected patients will develop renal complications related to cysts during their life, but may sometimes also develop severe extrarenal complications. The aim of this study is to review quantitative and qualitative results of researches that have investigated quality of life of patients suffering ADPKD. The results obtained with health-relative quality of life scales are contradictory and lack of sensibility according to the special features of ADPKD, for psychological impact for instance. Quality of life is decreased according to the quality of life scales specific to the ADPKD and qualitative studies from the early stages of the kidney failure with respect to physical (pain) and psychological impact of the disease. Untreated anxiety and depression are diagnosed for a significant part of patients. Uncertainty of prognosis, genetic guilt, precariousness of parental future, feelings of powerlessness and hopelessness are responsible at least in part of these disorders. According to the patients, pain remains underestimated by physicians and treatments are considered as insufficiently effective.
Copyright © 2017 Société francophone de néphrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Autosomal dominant polycystic kidney disease; Douleur; Mental suffering; Pain; Polykystose rénale autosomique dominante; Quality of life; Qualité de vie; Souffrance mentale

Mesh:

Year:  2017        PMID: 28606406     DOI: 10.1016/j.nephro.2016.12.005

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  2 in total

1.  The relationship between depression, anxiety, quality of life levels, and the chronic kidney disease stage in the autosomal dominant polycystic kidney disease.

Authors:  Aysenur Miray Yarlioglu; Ebru Gok Oguz; Ayse Gokcen Gundogmus; Kadir Gokhan Atilgan; Hatice Sahin; Mehmet Deniz Ayli
Journal:  Int Urol Nephrol       Date:  2022-10-02       Impact factor: 2.266

2.  Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.

Authors:  Dominique Joly; Jennifer Quinn; Stella Mokiou; Karl O'Reilly; Joaquín Sánchez-Covisa; Jing Wang-Silvanto; Helen Doll
Journal:  BMC Nephrol       Date:  2020-07-24       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.